Story

Oura Health Reportedly Targeting Up to $3 Billion in US IPO at Over $16 Billion Valuation

ENTHMSVIIDZHZH-TWJAKOHI
Aug 24, 20262 min read
Oura Health Reportedly Targeting Up to $3 Billion in US IPO at Over $16 Billion Valuation
Text size
Background

Smart ring maker Oura Health Oy is reportedly targeting a U.S. initial public offering that could raise as much as $3 billion and value the company at more than $16 billion. The listing could take place as early as September, according to a Bloomberg News report citing people familiar with the matter.

Offering Details

The proposed offering would include shares sold by both the company and select existing investors, who are expected to sell a significant portion of their stock, the report said. Deliberations remain ongoing, and the size and timing of the deal could still change. Oura confidentially filed for an IPO in May.

The potential $16 billion-plus valuation represents a notable increase from the $11 billion valuation the company achieved last September after an $875 million Series E funding round. To manage the transaction, Oura is reportedly working with an underwriting syndicate that includes Goldman Sachs Group Inc., Morgan Stanley, and JPMorgan Chase & Co.

Market Position and Competition

Sample IUX Markets – In-articleAd

Oura has carved out a niche in the consumer health market with its discrete, ring-based device that tracks sleep, fitness, and other health metrics. The form factor has appealed to users seeking an alternative to larger smartwatches, positioning Oura as a prominent name in specialized health hardware.

However, the company's move to go public comes as competition intensifies. Established technology giants are increasingly entering the space, with Samsung Electronics Co. having introduced its own smart ring and Apple Inc. reportedly developing a range of new AI-powered wearables.

Strategic Implications

A successful IPO would bolster Oura's balance sheet with significant liquidity, providing the resources needed to defend its market share and invest in growth amid pressure from larger rivals. For investors, the offering will be a key test of the public market's appetite for high-growth consumer health technology and its willingness to support premium valuations in a competitive landscape.

Read next

More on Stocks
Back to latest news

LATEST